Results 211 to 220 of about 276,260 (291)

Efficacy and safety of SQ house dust mite sublingual immunotherapy-tablet (12 SQ-HDM) in children with allergic rhinitis/rhinoconjunctivitis with or without asthma (MT-12): a randomised, double-blind, placebo-controlled, phase III trial

open access: gold
Antje Schuster   +9 more
openalex   +1 more source

Effect of house dust mite sublingual immunotherapy in patients with adult atopic dermatitis with rhinitis. [PDF]

open access: yesFuture Sci OA
Mizuno M   +7 more
europepmc   +1 more source

Mechanism differences in the start time of sublingual immunotherapy in a mouse allergic airway inflammation model. [PDF]

open access: yesSci Rep
Saito A   +13 more
europepmc   +1 more source

Effect of sublingual immunotherapy on clinical and laboratory autoimmunity. [PDF]

open access: yesImmunotherapy
Bozek A   +4 more
europepmc   +1 more source

Adherence and Clinical Outcome of Sublingual Immunotherapy for Japanese Cedar Pollinosis

open access: diamond, 2016
Atsushi Yuta   +6 more
openalex   +2 more sources

Treatment with the SQ tree sublingual immunotherapy tablet is safe and well tolerated in real-life. [PDF]

open access: yesClin Transl Allergy
Pfaar O   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy